Using a humanised murine model of FA we demonstrated that treatment with the stem cell mobilising cytokines granulocyte-colony stimulating factor (G-CSF) and stem cell factor had pronounced effects on frataxin levels within the nervous system and improved clinical, biochemical and pathological parameters associated with the disease10,11. The gene discussed is CSF3; the disease is Friedreich ataxia.